Effect of vitamin D on brain development during ontogenesis: literature review

Abstract

The article presents a review. Information on metabolism of vitamin D and its significance in the formation of the brain in the prenatal and postnatal periods is given. An up-to-date data regarding the effect of vitamin D on neurogenesis, activity of neurotransmitter systems, formation of cognitive status and quality of emotional state in children and adolescents is analyzed. The role of vitamin D in pathogenesis of autistic spectrum disorders, resistant forms of epilepsy, deviant variants of development in children is discussed.

Keywords

vitamin D deviant variants of development in children / D hypovitaminosis

References

[1] Riggs B.L., Melton L.J. Osteoporosis. Etiology, diagnosis, treatment. Translated from English. Moscow – St. Petersburg: BINOM: Nevsky dialect 2000; 560 (in Russian).

[2] Риггз Б.Л., Мелтон Л.Дж. Остеопороз. Этиология, диагностика, лечение: пер. с англ. М.–СПб: БИНОМ: Невский диалект, 2000; 560.

[3] Schwartz G.Ya. Renaissance of vitamin D: molecular biological, physiological and pharmacological aspects. Medical Council 2015; 18: 102–110 (in Russian).

[4] Шварц Г.Я. Ренессанс витамина D: молекулярно-биологические, физиологические и фармакологические аспекты. Медицинский совет 2015; 18: 102–110.

[5] Wierzbicka J, Piotrowska A, Żmijewski MA. The renaissance of vitamin D. Acta Biochim Pol 2014; 61 (4): 679–86.

[6] Wierzbicka J., Piotrowska A., Żmijewski M.A. The renaissance of vitamin D. Acta Biochim Pol, 2014; 61 (4): 679–86.

[7] Houston D.K. Vitamin D and Age-Related Health Outcomes: Movement, Mood, and Memory. Curr. Nutr. Rep. 2015; 4 (2): 185–200.

[8] Holick M.F. Vitamin D deficiency. N Engl J Med. 2007; 357: 266–81.

[9] Prosser, D.E., Jones, G. Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem Sci. 2004; 29 (12): 664–673.

[10] Prosser D.E., Jones G. Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem Sci. 2004; 29: 12: 664–673.

[11] Maltsev S.V., Arkhipova N.N., Shakirova E.M. Vitamin D, calcium and phosphates in healthy children and in pathology. Kazan 2012; 120 (in Russian).

[12] Мальцев С.В., Архипова Н.Н., Шакирова Э.М. Витамин D, кальций и фосфаты у здоровых детей и при патологии. Казань 2012; 120.

[13] Maltsev S.V. Rickets Rational pharmacotherapy of children's diseases. Moscow: Litterra 2007; 285–297 (in Russian).

[14] Мальцев С.В. Рахит. Рациональная фармакотерапия детских заболеваний. М.: Литтерра 2007; 285–297.

[15] Sanderson S.L. Nutritional Strategies in Gastrointestinal Disease. Canine and Feline Gastroenterology 2013; 409–428.

[16] Bikle D. Vitamin D and Immune Function: Understanding Common Pathways. Curr. Osteoporos. Rep. 2009; 7: 58–63.

[17] Drocourt L., Ourlin J.C., Parcussi J.M. et al. Expression of CYP3A4, CYP2B6, and CYP2C9 is regulated by the vitamin D receptor pathway in primary human hepatocytes. J. Biol. Chem. 2002; 277: 25–32.

[18] Maltsev S.V., Arkhipova N.N. Vitamin D in the practice of pediatrician. Practical medicine 2008; 06 (08): 12–23 (in Russian).

[19] Мальцев С.В., Архипова Н.Н. Витамин D в практике педиатра. Практическая медицина. 2008; 06 (08): 12–23.

[20] Spirichev V.B. About the biological effects of vitamin D. Pediatrics 2011; 90 (6): 113–119 (in Russian).

[21] Спиричев В.Б. О биологических эффектах витамина D. Педиатрия 2011; 90, 6; 113–119.

[22] Norman A.W., Bouillon R. Vitamin D nutritional policy needs a vision for the future. Exp. Biol. Med. 2010; 235 (9): 1034–1045.

[23] Ganguly A., Tamblyn J.A., Finn-Sell S. Vitamin D, the placenta and early pregnancy: effects on trophoblast function. J Endocrinol. 2018; 236 (2): 93–103.

[24] Hollis B.W., Wagner C.L. Vitamin D supplementation during pregnancy: Improvements in birth outcomes and complications through direct genomic alteration. Mol Cell Endocrinol. 2017; 453: 113–130.

[25] Murthi P., Yong H.E., Ngyuen T.P. Role of the Placental Vitamin D Receptor in Modulating Feto-Placental Growth in Fetal Growth Restriction and Preeclampsia-Affected Pregnancies. Front Physiol. 2016; 7: 43.

[26] Li N., Wu H.M., Hang F. Women with recurrent spontaneous abortion have decreased 25(OH) vitamin D and VDR at the fetalmaternal interface. Brazil J Med Biol Res. 2017; 50 (11): 6527.

[27] Li N., Wu H.M., Hang F. Women with recurrent spontaneous abortion have decreased 25 (OH) vitamin D and VDR at the fetalmaternal interface. Brazil J Med Biol Res. 2017; 50 (11): 6527.

[28] Munger K.L., Åivo J., Hongell K. Vitamin D Status During Pregnancy and Risk of Multiple Sclerosis in Offspring of Women in the Finnish Maternity Cohort. JAMA Neurol. 2016; 73 (5): 515–519.

[29] Taheri M., Baheiraei A., Foroushani A.R. Treatment of vitamin D deficiency is an effective method in the elimination of asymptomatic bacterial vaginosis: A placebo-controlled randomized clinical trial. Indian J Med Res. 2015; 141 (6): 799–806.

[30] Reusheva S.V., Panicheva E.A., Pastukhova S.Yu., Reushev M.Yu. The importance of vitamin D deficiency in the development of human diseases. The successes of modern natural science 2013; 11: 27–31 (in Russian).

[31] Реушева С.В., Паничева Е.А., Пастухова С.Ю., Реушев М.Ю. Значение дефицита витамина D в развитии заболеваний человека. Успехи современного естествознания 2013; 11: 27–31.

[32] Vitamin D deficiency in children and adolescents in the Russian Federation: modern approaches to correction: National program. Moscow 2015; 112 (in Russian).

[33] Недостаточность витамина D у детей и подростков в Российской Федерации: современные подходы к коррекции: национальная программа. М. 2015; 112.

[34] Minna Sucksdorff, Alan S. Brown, Roshan Chudal, Heljä-Marja Surcel, Susanna Hinkka-Yli-Salomäki, Keely Cheslack-Postava, David Gyllenberg, Andre Sourander. Modulation of the sympathetic nervous system in youngsters by vitamin-D supplementation. Physiol Rep. 2018; 6 (7): e13635.

[35] Minna Sucksdorff, Alan S Brown, Roshan Chudal, Heljä-Marja Surcel, Susanna Hinkka-Yli-Salomäki, Keely Cheslack-Postava, David Gyllenberg, Andre Sourander. Modulation of the sympathetic nervous system in youngsters by vitamin-D supplementation. Physiol Rep. 2018; 6 (7): e13635.

[36] Hanieh S., Ha T.T., Simpson J.A., Thuy T.T., Khuong N.C., Thoang D.D., Tran T.D., Tuan T., Fisher J., Biggs B.A. Maternal vitamin D status and infant outcomes in rural Vietnam: a prospective cohort study. PLoS. One. 2014; 9 (6).

[37] Zhu P., Tong S.L., Hao J.H., Tao R.X., Huang K., Hu W.B., Zhou Q.F., Jiang X.M., Tao F.B. Cord blood vitamin D and neurocognitive development are nonlinearly related in toddlers. J. Nutr. 2015; 145 (6): 1232–38.

[38] Minna Sucksdorff, Alan S Brown, Roshan Chudal, Heljä-Marja Surcel, Susanna Hinkka-Yli-Salomäki, Keely Cheslack-Postava, David Gyllenberg, Andre Sourander. Modulation of the sympathetic nervous system in youngsters by vitamin-D supplementation. Physiol Rep. 2018; 6 (7): e13635.

[39] Turner K.M., Young J.W., McGrath J.J., Eyles D.W., Burne T.H. Cognitive performance and response inhibition in developmentally vitamin D (DVD)-deficient rats. Behav. Brain. Res. 2013; 242: 47–53.

[40] Grecksch G., Ruthrich H., Hollt V., Becker A. Transient prenatal vitamin D deficiency is associated with changes of synaptic plasticity in the dentate gyrus in adult rats. Psychoneuroendocrino. 2009; 34 (1): 258–264.

[41] Grecksch G., Ruthrich H., Hollt V., Becker A. Transient prenatal vitamin D deficiency is associated with changes of synaptic plasticity in the dentate gyrus in adult rats. Psychoneuroendocrino. 2009; 34 (1): 258–64.

[42] Abhijit Chaudhuri. Why we should offer routine vitamin D supplementation in pregnancy and childhood to prevent multiple sclerosis. Med Hypotheses. 2005; 64 (3): 608–618.

[43] Abhijit Chaudhuri. Why we should offer routine vitamin D supplementation in pregnancy and childhood to prevent multiple sclerosis. Med Hypotheses. 2005; 64 (3): 608–18.

[44] Sherrill J Brown. The role of vitamin D in multiple sclerosis. Ann Pharmacother. 2006; 40 (6): 1158–1161.

[45] Sherrill J Brown. The role of vitamin D in multiple sclerosis. Ann Pharmacother. 2006; 40 (6): 1158–61.

[46] DeLuca G.C., Kimball S.M., Kolasinski J., Ramagopalan S.V., Ebers G.C. Review: the role of vitamin D in nervous system health and disease. Neuropathol Appl Neurobiol 2013; 39 (5): 458–84.

[47] Rita Moretti, Maria Elisa Morelli, Paola Caruso. Vitamin D in Neurological Diseases: A Rationale for a Pathogenic Impact. Int J Mol Sci. 2018; 19 (8): 2245.

[48] Natalie J Groves, John J McGrath, Thomas H J Burne. Vitamin D as a neurosteroid affecting the developing and adult brain. Annu Rev Nutr. 2014; 34: 117–41.

[49] Natalie J. Groves, John J. McGrath, Thomas H.J. Burne. Vitamin D as a neurosteroid affecting the developing and adult brain. Annu Rev Nutr. 2014; 34: 117–41.

[50] Sultan S., Taimuri U., Basnan S.A., Ai-Orabi W.K., Awadallah A., Almowald F., Hazazi A. Low Vitamin D and Its Association with Cognitive Impairment and Dementia. J Aging Res. 2020; 2020: 6097820.

[51] Torshin I.YU., Limanova O.A., Sardaryan I.S., Gromova O.A., Malyavskaya S.I., Grishina T.R., Galustyan A.N., Volkov A.Yu., Kalacheva A.G., Gromov A.N., Rudakov K.V. Provision of vitamin D in children and adolescents aged 7 to 14 years and the relationship of deficiency of vitamin D with violations of children’s health: the analysis of a large-scale sample of patients by means of data mining. Pediatrics named after G.N. Speransky. 2015; 94 (2) (in Russian).

[52] Торшин И.Ю., Громова О.А., Лиманова О.А., Сардарян И.С., Малявская С.И., Гришина Т.Р., Галустян А.Н., Волков А.Ю., Калачева А.Г., Громов А.Н., Рудаков К.В. Обеспеченность витамином D детей и подростков 7–14 лет и взаимосвязь дефицита витамина D с нарушениями здоровья детей. Анализ крупномасштабной выборки пациентов посредством интеллектуального анализа данных. Педиатрия. Журнал им. Г.Н. Сперанского. 201; 94 (2): 175–84.

[53] Ibi M., Sawada H., Nakanishi M., Kume T., Katsuki H., Kaneko S., Shimohama S., Akaike A. Protective effects of 1 alpha,25-(OH) (2) D (3) against the neurotoxicity of glutamate and reactive oxygen species in mesencephalic culture. Neuropharmacology 2001; 40 (6): 761–771.

[54] Ibi M., Sawada H., Nakanishi M., Kume T., Katsuki H., Kaneko S., Shimohama S., Akaike A. Protective effects of 1 alpha,25-(OH) (2)D(3) against the neurotoxicity of glutamate and reactive oxygen species in mesencephalic culture. Neuropharmacology 2001; 40 (6): 761–71.

[55] Brion F., Dupuis Y. Calcium and monoamine regulation: role of vitamin D nutrition. Can. J. Physiol. Pharmacol. 1980; 58 (12): 1431–1434.

[56] Brion F., Dupuis Y. Calcium and monoamine regulation: role of vitamin D nutrition. Can. J. Physiol. Pharmacol. 1980; 58 (12): 1431–34.

[57] Minna Sucksdorff, Alan S Brown, Roshan Chudal, Heljä-Marja Surcel, Susanna Hinkka-Yli-Salomäki, Keely Cheslack-Postava, David Gyllenberg, Andre Sourander. Modulation of the sympathetic nervous system in youngsters by vitamin-D supplementation. Physiol Rep. 2018; 6 (7): e13635.

[58] Małgorzata Wrzosek, Jacek Łukaszkiewicz, Michał Wrzosek, Andrzej Jakubczyk, HalinaMatsumoto, Paweł Piątkiewicz, Maria Radziwoń-Zaleska, Marcin Wojnar, Grażyna Nowicka. Vitamin D and the central nervous system. Pharmacol Rep. 2013; 65 (2): 271–278.

[59] Małgorzata Wrzosek, Jacek Łukaszkiewicz, Michał Wrzosek, Andrzej Jakubczyk, HalinaMatsumoto, Paweł Piątkiewicz, Maria Radziwoń-Zaleska, Marcin Wojnar, Grażyna Nowicka. Vitamin D and the central nervous system. Pharmacol Rep. 2013; 65 (2): 271–8.

[60] Kryzhanovskaya S.Yu., Zapara M.A., Glazachev O.S. Neurotrophins and Adaptation to Environmental Stimuli: Opportunities for Expanding «Therapeutic Capacity» (Mini-Review). Vestnik Mezhdunarodnoj akademii nauk. Russkaya sekciya 2020; 1 (in Russian).

[61] Крыжановская С.Ю., Запара М.А., Глазачев О.С. Нейротрофины и адаптация ксредовым стимулам: возможности расширения «терапевтического потенциала»; (краткий обзор). Вестник науки и образования. Русская секция 2020; 1.

[62] Gromova O.A., Torshin I.Yu., Pronin A.V., Gogoleva I.V., Maiorova L.A. Neurosteroid effects of vitamin D. role in pediatrics. Pharmateka 2015; 11: 78–87 (in Russian).

[63] Громова О.А., Торшин И.Ю., Пронин А.В., Гоголева И.В., Майорова Л.А. Нейростероидные эффекты витамина D. роль в педиатрии. Фарматека 2015; 11: 78–87.

[64] Gromova O.A., Torshin I.Yu. Vitamin D. Paradigm shift. Ed. E.I. Guseva, I.N. Zakharova. Moscow 2015; 464 (in Russian).

[65] Громова О.А., Торшин И.Ю. Витамин D. Смена парадигмы. Под ред. Е.И. Гусева, И.Н. Захаровой. М. 2015; 464.

[66] Zaharova I.N., Maltsev S.V., Borovik T.E., Yatsyk G.V., Malyavskaya S.I., Vahlova I.V., Shumatova T.A., Romantsova E.B., Romanyuk F.P., Klimov L.Y., Elkina T.N., Pirojkova N.I., Kolesnikova S.M., Kuryaninova V.A., Vasileva S.V., Mozzhuhina M.V., Evseeva E.A. Vitamin D deficiency in young children in Russia (results of a multicenter study – winter 2013–2014). Pediatrics named after G.N. Speransky. 2014; 93 (2) (in Russian).

[67] Захарова И.Н., Мальцев С.В., Боровик Г.В., Яцык Т.Э., Малявская С.И., Вахлова И.В., Шуматова Т.А., Романцова Е.Б., Романюк Ф.П., Климов Л.Я., Елкина Т.Н., Пирожкова Н.И., Колесникова С.М., Курьянинова В.А., Васильева С.В., Мозжухина М.В., Евсеева Е.А. Результаты многоцентрового исследования «РОДНИЧОК» по изучению недостаточности витамина D у детей раннего возраста в России. Педиатрия. Журнал им. Г.Н. Сперанского 2015; 1: 62–70.

[68] Nassar M.F., Amin D.A., Hamed A.I., Nassar J.F., Abou-Zeid A.E., Attaby M.A. Vitamin D status and scholastic achievement in middle age childhood. J. Egypt. Soc. Parasitol. 2012; 42 (2): 349–58.

[69] Frandsen T.B., Pareek M., Hansen J.P., Nielsen C.T. Vitamin D supplementation for treatment of seasonal affective symptoms in healthcare professionals: a double-blind randomised placebo-controlled trial. BMC. Res. Notes. 2014; 7: 528.

[70] Grudet C., Malm.J, Westrin A., Brundin L. Suicidal patients are deficient in vitamin D, associated with a pro-inflammatory status in the blood. Psychoneuroendocrinology. 2014; 50: 210–219.

[71] Grudet C., Malm.J, Westrin A., Brundin L. Suicidal patients are deficient in vitamin D, associated with a pro-inflammatory status in the blood. Psychoneuroendocrinology 2014; 50: 210–19.

[72] Giovanni Battista Dell'Isola, Eleonora Tulli, Rossella Sica, Valerio Vinti, Elisabetta Mencaroni, Giuseppe Di Cara, Pasquale Striano, Alberto Verrotti. The Vitamin D Role in Preventing Primary Headache in Adult and Pediatric Population. J Clin Med. 2021; 10 (24): 5983.

[73] Magdalena Nowaczewska, Michał Wiciński, Stanisław Osiński, Henryk Kaźmierczak. The Role of Vitamin D in Primary Headache-from Potential Mechanism to Treatment. Nutrients. 2020; 12 (1): 243.

[74] Tyutyunnikova N.B. Autism spectrum disorders. Archivarius 2019; 11 (44) (in Russian).

[75] Тютюнникова Н.Б. Расстройства аутистического спектра. Архивариус 2019; 11 (44).

[76] Martina Siracusano, Assia Riccioni, Roberta Abate, Arianna Benvenut, Paolo Curatolo, Luigi Mazzone. Vitamin D Deficiency and Autism Spectrum Disorder. Curr Pharm Des. 2020; 26 (21): 2460–2474.

[77] Junyan Feng, Ling Shan, Lin Du, Bing Wang, Honghua Li, Wei Wang, Tiantian Wang, Hanyu Dong, Xiaojing Yue, Zhida Xu, Wouter G Staal, Feiyong Jia. Clinical improvement following vitamin D3 supplementation in Autism Spectrum Disorder. Nutr Neurosci. 2017; 20 (5): 284–290.

[78] John Jacob Cannell. Vitamin D and autism, what's new? Rev Endocr Metab Disord. 2017; 18 (2): 183–193.

[79] Christopher M DeGiorgio, Dieter Hertling, Ashley Curtis, Diana Murray, Daniela Markovic. Safety and tolerability of Vitamin D3 5000 IU/day in epilepsy. Epilepsy Behav. 2019; 94: 195–197.

[80] Zhdanova L.I., Tomilov I.A., Schneider N.A., Botyanovskaia O.V. Multiple sclerosis in children. Bulletin of the Clinical Hospital 2008; 51: 2 (in Russian).

[81] Жданова Л.И., Томилов И.А., Шнайдер Н.А., Ботяновская О.В. Рассеянный склероз у детей. Вестник Клинической больницы 2008; 51; 2.

[82] Charles Pierrot-Deseilligny, Jean-Claude Souberbielle. Is hypovitaminosis D one of the environmental risk factors for multiple sclerosis? Brain. 2010; 133 (7): 1869–88.

RIGHTS & PERMISSIONS

Eco-Vector